A citation-based method for searching scientific literature

Isaac Kinde, Enrico Munari, Sheila F Faraj, Ralph H Hruban, Mark Schoenberg, Trinity Bivalacqua, Mohamad Allaf, Simeon Springer, Yuxuan Wang, Luis A Diaz, Kenneth W Kinzler, Bert Vogelstein, Nickolas Papadopoulos, George J Netto. Cancer Res 2013
Times Cited: 162







List of co-cited articles
1233 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal.
Patrick J Killela, Zachary J Reitman, Yuchen Jiao, Chetan Bettegowda, Nishant Agrawal, Luis A Diaz, Allan H Friedman, Henry Friedman, Gary L Gallia, Beppino C Giovanella,[...]. Proc Natl Acad Sci U S A 2013
841
40

Highly recurrent TERT promoter mutations in human melanoma.
Franklin W Huang, Eran Hodis, Mary Jue Xu, Gregory V Kryukov, Lynda Chin, Levi A Garraway. Science 2013
36

Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome.
Yves Allory, Willemien Beukers, Ana Sagrera, Marta Flández, Miriam Marqués, Mirari Márquez, Kirstin A van der Keur, Lars Dyrskjot, Irene Lurkin, Marcel Vermeij,[...]. Eur Urol 2014
155
35

TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
33


Frequency of TERT promoter mutations in human cancers.
João Vinagre, Ana Almeida, Helena Pópulo, Rui Batista, Joana Lyra, Vasco Pinto, Ricardo Coelho, Ricardo Celestino, Hugo Prazeres, Luis Lima,[...]. Nat Commun 2013
505
27

TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism.
P Sivaramakrishna Rachakonda, Ismail Hosen, Petra J de Verdier, Mahdi Fallah, Barbara Heidenreich, Charlotta Ryk, N Peter Wiklund, Gunnar Steineck, Dirk Schadendorf, Kari Hemminki,[...]. Proc Natl Acad Sci U S A 2013
205
26

Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer.
Sumit Borah, Linghe Xi, Arthur J Zaug, Natasha M Powell, Garrett M Dancik, Scott B Cohen, James C Costello, Dan Theodorescu, Thomas R Cech. Science 2015
186
24

Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy.
Simeon U Springer, Chung-Hsin Chen, Maria Del Carmen Rodriguez Pena, Lu Li, Christopher Douville, Yuxuan Wang, Joshua David Cohen, Diana Taheri, Natalie Silliman, Joy Schaefer,[...]. Elife 2018
65
33

Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer.
Robert J A Bell, H Tomas Rube, Alex Kreig, Andrew Mancini, Shaun D Fouse, Raman P Nagarajan, Serah Choi, Chibo Hong, Daniel He, Melike Pekmezci,[...]. Science 2015
285
19

High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions.
Jean Charles Nault, Maxime Mallet, Camilla Pilati, Julien Calderaro, Paulette Bioulac-Sage, Christophe Laurent, Alexis Laurent, Daniel Cherqui, Charles Balabaud, Jessica Zucman-Rossi. Nat Commun 2013
359
19

Specific association of human telomerase activity with immortal cells and cancer.
N W Kim, M A Piatyszek, K R Prowse, C B Harley, M D West, P L Ho, G M Coviello, W E Wright, S L Weinrich, J W Shay. Science 1994
18

Mutations in TERT promoter and FGFR3 and telomere length in bladder cancer.
Ismail Hosen, P Sivaramakrishna Rachakonda, Barbara Heidenreich, Petra J de Verdier, Charlotta Ryk, Gunnar Steineck, Kari Hemminki, Rajiv Kumar. Int J Cancer 2015
56
32

Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.
A Gordon Robertson, Jaegil Kim, Hikmat Al-Ahmadie, Joaquim Bellmunt, Guangwu Guo, Andrew D Cherniack, Toshinori Hinoue, Peter W Laird, Katherine A Hoadley, Rehan Akbani,[...]. Cell 2017
741
18

Non-invasive prediction of recurrence in bladder cancer by detecting somatic TERT promoter mutations in urine.
Françoise Descotes, Norelyakin Kara, Myriam Decaussin-Petrucci, Eric Piaton, Florence Geiguer, Claire Rodriguez-Lafrasse, Jean E Terrier, Jonathan Lopez, Alain Ruffion. Br J Cancer 2017
38
44

High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other origins.
Xiaoyong Zheng, Jian Zhuge, Stephania M Bezerra, Sheila F Faraj, Enrico Munari, John T Fallon, Ximing J Yang, Pedram Argani, George J Netto, Minghao Zhong. J Hematol Oncol 2014
43
34


Genomic complexity of urothelial bladder cancer revealed in urinary cfDNA.
Fiona S Togneri, Douglas G Ward, Joseph M Foster, Adam J Devall, Paula Wojtowicz, Sofia Alyas, Fabiana Ramos Vasques, Assa Oumie, Nicholas D James, K K Cheng,[...]. Eur J Hum Genet 2016
70
21

Next-generation Sequencing of Nonmuscle Invasive Bladder Cancer Reveals Potential Biomarkers and Rational Therapeutic Targets.
Eugene J Pietzak, Aditya Bagrodia, Eugene K Cha, Esther N Drill, Gopa Iyer, Sumit Isharwal, Irina Ostrovnaya, Priscilla Baez, Qiang Li, Michael F Berger,[...]. Eur Urol 2017
128
15

High prevalence of TERT promoter mutations in primary squamous cell carcinoma of the urinary bladder.
Morgan Cowan, Simeon Springer, Doreen Nguyen, Diana Taheri, Gunes Guner, Maria Angelica Mendoza Rodriguez, Yuxuan Wang, Isaac Kinde, Christopher J VandenBussche, Matthew T Olson,[...]. Mod Pathol 2016
22
63

Understanding TERT Promoter Mutations: A Common Path to Immortality.
Robert J A Bell, H Tomas Rube, Ana Xavier-Magalhães, Bruno M Costa, Andrew Mancini, Jun S Song, Joseph F Costello. Mol Cancer Res 2016
107
14

TERT promoter mutations in cancer development.
Barbara Heidenreich, P Sivaramakrishna Rachakonda, Kari Hemminki, Rajiv Kumar. Curr Opin Genet Dev 2014
140
14

High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma.
Doreen Nguyen, Diana Taheri, Simeon Springer, Morgan Cowan, Gunes Guner, Maria Angelica Mendoza Rodriguez, Yuxuan Wang, Isaac Kinde, Christopher J VandenBussche, Matthew T Olson,[...]. Virchows Arch 2016
24
58


Liquid Biopsy Analysis of FGFR3 and PIK3CA Hotspot Mutations for Disease Surveillance in Bladder Cancer.
Emil Christensen, Karin Birkenkamp-Demtröder, Iver Nordentoft, Søren Høyer, Kirstin van der Keur, Kim van Kessel, Ellen Zwarthoff, Mads Agerbæk, Torben Falck Ørntoft, Jørgen Bjerggaard Jensen,[...]. Eur Urol 2017
89
15

Mutations in the promoter of the telomerase gene TERT contribute to tumorigenesis by a two-step mechanism.
Kunitoshi Chiba, Franziska K Lorbeer, A Hunter Shain, David T McSwiggen, Eva Schruf, Areum Oh, Jekwan Ryu, Xavier Darzacq, Boris C Bastian, Dirk Hockemeyer. Science 2017
117
14

Detection of TERT promoter mutations in primary adenocarcinoma of the urinary bladder.
Morgan L Cowan, Simeon Springer, Doreen Nguyen, Diana Taheri, Gunes Guner, Maria Angelica Mendoza Rodriguez, Yuxuan Wang, Isaac Kinde, Maria Del Carmen Rodriguez Pena, Christopher J VandenBussche,[...]. Hum Pathol 2016
21
66

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
13

Cancer-associated TERT promoter mutations abrogate telomerase silencing.
Kunitoshi Chiba, Joshua Z Johnson, Jacob M Vogan, Tina Wagner, John M Boyle, Dirk Hockemeyer. Elife 2015
139
13

Recurrent TERT promoter mutations identified in a large-scale study of multiple tumour types are associated with increased TERT expression and telomerase activation.
Dong-Sheng Huang, Zhaohui Wang, Xu-Jun He, Bill H Diplas, Rui Yang, Patrick J Killela, Qun Meng, Zai-Yuan Ye, Wei Wang, Xiao-Ting Jiang,[...]. Eur J Cancer 2015
95
13

Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers.
Josh Lewis Stern, Dan Theodorescu, Bert Vogelstein, Nickolas Papadopoulos, Thomas R Cech. Genes Dev 2015
95
13

TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma.
Klaus G Griewank, Rajmohan Murali, Joan Anton Puig-Butille, Bastian Schilling, Elisabeth Livingstone, Miriam Potrony, Cristina Carrera, Tobias Schimming, Inga Möller, Marion Schwamborn,[...]. J Natl Cancer Inst 2014
147
13

Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma.
Jakob Hedegaard, Philippe Lamy, Iver Nordentoft, Ferran Algaba, Søren Høyer, Benedicte Parm Ulhøi, Søren Vang, Thomas Reinert, Gregers G Hermann, Karin Mogensen,[...]. Cancer Cell 2016
259
13

Multiplex PCR and Next Generation Sequencing for the Non-Invasive Detection of Bladder Cancer.
Douglas G Ward, Laura Baxter, Naheema S Gordon, Sascha Ott, Richard S Savage, Andrew D Beggs, Jonathan D James, Jennifer Lickiss, Shaun Green, Yvonne Wallis,[...]. PLoS One 2016
44
29

Recurrent TERT promoter mutations in urothelial carcinoma and potential clinical applications.
Boaz Kurtis, Jian Zhuge, Caroline Ojaimi, Fei Ye, Dongming Cai, David Zhang, John T Fallon, Minghao Zhong. Ann Diagn Pathol 2016
20
60

The Genetic Evolution of Melanoma from Precursor Lesions.
A Hunter Shain, Iwei Yeh, Ivanka Kovalyshyn, Aravindhan Sriharan, Eric Talevich, Alexander Gagnon, Reinhard Dummer, Jeffrey North, Laura Pincus, Beth Ruben,[...]. N Engl J Med 2015
449
12

Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss.
Hideyuki Arita, Yoshitaka Narita, Shintaro Fukushima, Kensuke Tateishi, Yuko Matsushita, Akihiko Yoshida, Yasuji Miyakita, Makoto Ohno, V Peter Collins, Nobutaka Kawahara,[...]. Acta Neuropathol 2013
219
12

Mutations of the TERT promoter are common in basal cell carcinoma and squamous cell carcinoma.
Glynis A Scott, Todd S Laughlin, Paul G Rothberg. Mod Pathol 2014
65
18

Telomerase reverse transcriptase gene promoter mutations help discern the origin of urogenital tumors: a genomic and molecular study.
Song Wu, Peide Huang, Chong Li, Yi Huang, Xianxin Li, Yongqiang Wang, Chao Chen, Zhaojie Lv, Aifa Tang, Xiaojuan Sun,[...]. Eur Urol 2014
64
18

Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy.
Woonyoung Choi, Sima Porten, Seungchan Kim, Daniel Willis, Elizabeth R Plimack, Jean Hoffman-Censits, Beat Roth, Tiewei Cheng, Mai Tran, I-Ling Lee,[...]. Cancer Cell 2014
835
12

EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.
Marko Babjuk, Andreas Böhle, Maximilian Burger, Otakar Capoun, Daniel Cohen, Eva M Compérat, Virginia Hernández, Eero Kaasinen, Joan Palou, Morgan Rouprêt,[...]. Eur Urol 2017
12

Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer.
Faysal A Yafi, Fadi Brimo, Jordan Steinberg, Armen G Aprikian, Simon Tanguay, Wassim Kassouf. Urol Oncol 2015
105
11

Highly prevalent TERT promoter mutations in aggressive thyroid cancers.
Xiaoli Liu, Justin Bishop, Yuan Shan, Sara Pai, Dingxie Liu, Avaniyapuram Kannan Murugan, Hui Sun, Adel K El-Naggar, Mingzhao Xing. Endocr Relat Cancer 2013
353
11

A molecular taxonomy for urothelial carcinoma.
Gottfrid Sjödahl, Martin Lauss, Kristina Lövgren, Gunilla Chebil, Sigurdur Gudjonsson, Srinivas Veerla, Oliver Patschan, Mattias Aine, Mårten Fernö, Markus Ringnér,[...]. Clin Cancer Res 2012
419
11

Detection and quantification of rare mutations with massively parallel sequencing.
Isaac Kinde, Jian Wu, Nick Papadopoulos, Kenneth W Kinzler, Bert Vogelstein. Proc Natl Acad Sci U S A 2011
667
11

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.
Richard J Sylvester, Adrian P M van der Meijden, Willem Oosterlinck, J Alfred Witjes, Christian Bouffioux, Louis Denis, Donald W W Newling, Karlheinz Kurth. Eur Urol 2006
11

Spectrum of genetic mutations in de novo PUNLMP of the urinary bladder.
Maria Del Carmen Rodriguez Pena, Aline C Tregnago, Marie-Lisa Eich, Simeon Springer, Yuxuan Wang, Diana Taheri, Dilek Ertoy, Kazutoshi Fujita, Stephania M Bezerra, Isabela W Cunha,[...]. Virchows Arch 2017
15
73

Highly prevalent TERT promoter mutations in bladder cancer and glioblastoma.
Xiaoli Liu, Guojun Wu, Yuan Shan, Christian Hartmann, Andreas von Deimling, Mingzhao Xing. Cell Cycle 2013
95
10

The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas.
T Liu, N Wang, J Cao, A Sofiadis, A Dinets, J Zedenius, C Larsson, D Xu. Oncogene 2014
155
10



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.